JPS58167512A - Antitrichophytic agent - Google Patents

Antitrichophytic agent

Info

Publication number
JPS58167512A
JPS58167512A JP5019582A JP5019582A JPS58167512A JP S58167512 A JPS58167512 A JP S58167512A JP 5019582 A JP5019582 A JP 5019582A JP 5019582 A JP5019582 A JP 5019582A JP S58167512 A JPS58167512 A JP S58167512A
Authority
JP
Japan
Prior art keywords
osthole
agent
active constituent
ether
ointment
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP5019582A
Other languages
Japanese (ja)
Inventor
Mamoru Tabata
小沢貢
Yoshiaki Honda
田端守
Yasuhiko Hizuka
肥塚靖彦
Mitsugi Ozawa
馬場きみ江
Kimie Baba
本多義昭
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Mitsui Petrochemical Industries Ltd
Original Assignee
Mitsui Petrochemical Industries Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Mitsui Petrochemical Industries Ltd filed Critical Mitsui Petrochemical Industries Ltd
Priority to JP5019582A priority Critical patent/JPS58167512A/en
Publication of JPS58167512A publication Critical patent/JPS58167512A/en
Pending legal-status Critical Current

Links

Landscapes

  • Pyrane Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

PURPOSE:The titled stably usable agent, containing osthole as an active constituent, and having an antimicrobial activity against trichophytes. CONSTITUTION:An antitrichophytic agent containing osthole of the formula as an active constituent. In formulating the agent, the osthole is mixed with a liquid carrier, e.g. water, an alcohol or glycol ether, and used as a drug, e.g. tincture, or kneaded with a wax, e.g. polyethylene glycol 4000 or spermaceti wax, or another ointment base and used as an ointment for external application to an affected part. The content of the active constituent osthole is suitably 0.1-5wt% in general, and the osthole is the well-known compound and is obtained by extraction from Cnidium monnieri Cusson which is a Chinese herbal medicine used as an anti-inflammatory, astringent and invigorating drug with a non-aqueous solvent, e.g. methanol or ether.

Description

【発明の詳細な説明】 本発明は抗白解菌剤に関する。[Detailed description of the invention] The present invention relates to an antiwhitening agent.

すなわち一本発明は、下記の構造式 で表わされるオストール(osthol)を有効成分と
する抗白癖菌剤である。
That is, one aspect of the present invention is an anti-fungal agent containing osthol represented by the following structural formula as an active ingredient.

蛇床子は主に消炎,収斂,強精剤として用いられている
漢方薬であるが,本発明者等は,中国産蛇床子に上記オ
ストールが含まれていること,およびこのオストールが
抗白癖菌活性を有することを発見した。本発明はこの知
見に基いて完成されたものである。
Snake seeds are a Chinese herbal medicine that is mainly used as an anti-inflammatory, astringent, and tonic agent. The present inventors have discovered that Chinese snake seeds contain the above-mentioned ostol, and that this ostole has anti-white-bacteria activity. I discovered that it has. The present invention was completed based on this knowledge.

本発明で有効成分として使用するオス}−/レ&よヤ 公知の化合物で中国産蛇床子からメタノールーエーテル
のような非水溶媒を用いて抽出することにより得ること
ができることがわかった。なお,台湾産蛇床子にはオス
トールは含有されていない。
It has been found that the known compound used as an active ingredient in the present invention can be obtained by extracting it from Chinese chives using a non-aqueous solvent such as methanol-ether. Incidentally, Ostole is not contained in the Taiwanese snake roe.

中国産蛇床子からオストールを得る具体例な示すと.次
のとおりである。
Here is a specific example of obtaining ostole from china seedlings from China. It is as follows.

中国産蛇床子コtKyにメタノールλオ!を加え,常温
で70日間放置後,P過した抽出液を真空濃縮してメタ
ノールエキスユ3gノを得る。このメタノールエキス:
13gi!−にジエチルエーテルj!及び水i.tiを
加えてエーテルと水とで振り分けエーテル層/10g−
と水相7qg−を得る。
Methanol λo for Chinese snake roe tKy! After 70 days at room temperature, the P-filtered extract was concentrated in vacuo to obtain 3 g of methanol extract. This methanol extract:
13gi! -diethyl ether j! and water i. Add ti and divide between ether and water. Ether layer/10g-
and 7 qg of aqueous phase were obtained.

このエーテル層ノjO?をシリカゲル力ラムクロマトグ
ラフイーにかけ−n−ヘキ・サン:クロロホルム二/:
/の溶出剤で溶出し一得られた各分画についてペーパー
ディスク法で白鮮菌の一種であるトリコフイトン●メン
タグロフイテスIFO.tg09(Trichophy
tonmentagrophytesIFOsg09)
に対する抗菌活性を調べて主要活性分画からクロロホル
ム:n−ヘキサン混合溶媒を用いる再結晶法によりオス
トールを単離した。収量3a,271;10なお,上記
の主要活性分画から単離した成分がオストールであるこ
とは−その融点:g.tC−赤外純吸収スペクトル(ク
ロロホルム溶’Q):/7/gcm−’(C=O),i
toscm−’CC=O),/zt2Crn−’(芳香
族C=C).紫外線吸収スペクトル:メタノール λnm3−22.−21g+−Z’lg(should
er).maX 質量スペクトル:分子イオンピーク(m+/e)コll
lI,元素分析:実測値C7.?.ム24,H乙.島I
.予想含有率C7.7.7j4,H4,≦θ係であるこ
とからオストールと同定した。
This etheric layer? was subjected to silica gel force column chromatography - n-hexane:chloroform di/:
Each fraction obtained was eluted with an eluent of / and analyzed using the paper disk method to extract Trichophyton, a type of Bacillus aeruginosa, and Mentaglophytes IFO. tg09(Trichophy
tonmentagrophytesIFOsg09)
Ostol was isolated from the main active fraction by a recrystallization method using a mixed solvent of chloroform and n-hexane. Yield: 3a, 271; 10 The fact that the component isolated from the above-mentioned main active fraction is osthole - its melting point: g. tC-infrared pure absorption spectrum (chloroform solution 'Q): /7/gcm-' (C=O), i
toscm-'CC=O), /zt2Crn-' (aromatic C=C). Ultraviolet absorption spectrum: methanol λnm3-22. -21g+-Z'lg (should
er). maX mass spectrum: molecular ion peak (m+/e)
lI, elemental analysis: actual value C7. ? .. M24, H Otsu. Island I
.. Since the predicted content was C7.7.7j4, H4, ≦θ, it was identified as ostole.

オストールの白癖菌類に対する抗菌活性を.寒天平板希
釈法で調べた最小阻止濃度CM.I.C,)(mcノ/
彪)で示すと,第1表のとおりである〇オストールの他
の微生物に対する抗菌活性を,寒天平板希釈法で調べた
最小阻止濃度(M,I,C.)(mc9/ml)で示す
と,第2表のとおりである0上記の試験結果から,オス
トールが白癖菌に対し特に高い抗菌活性を示し,抗白癖
菌剤の有効成分として適することが認められる。
Ostol's antibacterial activity against white fungi. Minimum inhibitory concentration CM determined by agar plate dilution method. I. C,) (mcノ/
The antibacterial activity of osthole against other microorganisms is shown in the minimum inhibitory concentration (M, I, C.) (mc9/ml) determined by the agar plate dilution method. , as shown in Table 2.0 From the above test results, it is recognized that ostol exhibits particularly high antibacterial activity against the fungus Lepidoptera, and is suitable as an active ingredient of an anti-fungal agent.

次にオストールの毒性試験について述べる0オストール
のオリーブオイル懸濁液を作成し,この懸濁液をDDY
系マウスの雄(6週令一体重平均一オノ)の腹腔内に注
射して一/日間観察した。
Next, we will discuss the toxicity test of osthole.We prepared an olive oil suspension of 0 osthole and added this suspension to DDY.
It was intraperitoneally injected into male mice (6 weeks old, average weight: 1 mouse) and observed for 1 day.

その結果は次の第3表のとおりであってーLD,。は/
000m97Kgを越えることが認められる。
The results are shown in Table 3 below -LD. teeth/
It is permitted to exceed 97 kg for 000 m.

捷た−オストール/ノ,ウンデシレン酸0.−1ノ+サ
リチル酸0.+2,P−ポリエチレングリコール400
J?.ポリエチレングリコール40003ノの組成の軟
膏を人間の手のひらに塗布したところ−/週間経過後も
何の変化も認められなかった。
Ostol/undecylenic acid 0. -1 + salicylic acid 0. +2, P-polyethylene glycol 400
J? .. When an ointment with the composition of polyethylene glycol 40003 was applied to the palm of a human being, no change was observed even after a week had passed.

上記試験の結果から,オストールは抗白癖菌剤として安
定して使用しうろことが認められる。
From the results of the above tests, it is confirmed that Ostol can be used stably as an antifungal agent.

本発明の抗白鮮菌剤は−オストールを例えば水一アルコ
ール類,グリコールエーテル類などの液体担体と混和し
て液剤(例えばチンキ剤)として一またはオストールを
ワックス類(例えばボリエチレングリコール4000.
鯨蝋など),その他の軟膏基剤と混和して軟膏として患
部に外用する。
The antibacterial agent of the present invention is prepared by mixing ostol with a liquid carrier such as water, alcohols, glycol ethers, etc. to prepare a solution (for example, a tincture) or using ostol as a wax (for example, polyethylene glycol 4000.
Mix it with other ointment bases (such as spermaceti) and apply it externally to the affected area as an ointment.

本発明の抗白癖菌剤におけるオストールの含量は適当に
選ぶことができるが一通常0./−1重量係位が適当で
ある。
The content of osthole in the antiwhitening fungal agent of the present invention can be appropriately selected, but is usually 0. /-1 weight coefficient is appropriate.

次に本発明の実施例を示すが一本発明はこれにより制限
されるものではない。
Next, examples of the present invention will be shown, but the present invention is not limited thereto.

実施例1 オストール7重量部,ジエチルセバケートj重量部一サ
リチル酸グリコール!重量部一ポリエチレングリコール
400j4’重量部,ポリエチレングリコール4000
31重景部を均一に混和して/係軟膏を得た。この軟膏
を患部に外用する。
Example 1 Osthole 7 parts by weight, diethyl sebacate J parts by weight monoglycol salicylate! Part by weight - Polyethylene glycol 400j4' Part by weight, Polyethylene glycol 4000
No. 31 was mixed uniformly to obtain an ointment. Apply this ointment externally to the affected area.

実施例2 オストール/重量部,ジエチルセパケートIO重量部,
サリチル酸グリコール/0重量部,メチェチノレ $トン4to重量部,iタノール39重量部を混合シて
74チンキ剤を得た0このチンキ剤を患部に外用する。
Example 2 Osthole/parts by weight, diethyl sepacate IO parts by weight,
74 tincture was obtained by mixing 0 parts by weight of glycol salicylate, 4 parts by weight of mechetinole, and 39 parts by weight of ethanol.This tincture was applied externally to the affected area.

Claims (1)

【特許請求の範囲】 下記の構造式 で表わされるオストールを有効成分とする抗白癖菌斉り
[Scope of Claims] An anti-white fungus product containing ostol represented by the following structural formula as an active ingredient.
JP5019582A 1982-03-30 1982-03-30 Antitrichophytic agent Pending JPS58167512A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP5019582A JPS58167512A (en) 1982-03-30 1982-03-30 Antitrichophytic agent

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP5019582A JPS58167512A (en) 1982-03-30 1982-03-30 Antitrichophytic agent

Publications (1)

Publication Number Publication Date
JPS58167512A true JPS58167512A (en) 1983-10-03

Family

ID=12852362

Family Applications (1)

Application Number Title Priority Date Filing Date
JP5019582A Pending JPS58167512A (en) 1982-03-30 1982-03-30 Antitrichophytic agent

Country Status (1)

Country Link
JP (1) JPS58167512A (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN114989122A (en) * 2022-05-16 2022-09-02 武汉安慧生物科技有限公司 Preparation method of osthole and pimpinellide

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN114989122A (en) * 2022-05-16 2022-09-02 武汉安慧生物科技有限公司 Preparation method of osthole and pimpinellide

Similar Documents

Publication Publication Date Title
WO2003045411A3 (en) Ginger extract preparation
CA2491613A1 (en) An hydroxytyrosol-rich composition from olive vegetation water and method of use thereof
Oelrichs et al. Isolation of a compound from Eupatorium adenophorum (Spreng.)[Ageratina adenophora (Spreng.)] causing hepatotoxicity in mice
US20080138299A1 (en) Oral Pharmaceuticals or Oral Hygiene Products Comprising Licorice Flavonoid Extract
Mitsuhashi et al. Studies on the constituents of Umbelliferae plants. II. Isolation of the active principles of Ligusticum root
US5691386A (en) Triterpenoid compound for the treatment of diabetes
Yemoa et al. Beninese medicinal plants as a source of antimycobacterial agents: bioguided fractionation and in vitro activity of alkaloids isolated from Holarrhena floribunda used in traditional treatment of buruli ulcer
Li et al. Two new benzylisoquinoline alkaloids from Thalictrum foliolosum and their antioxidant and in vitro antiproliferative properties
Gu et al. Quantitative evaluation of Annonaceous acetogenins in monthly samples of paw paw (Asimina triloba) twigs by liquid chromatography/electrospray ionization/tandem mass spectrometry
Jose et al. Identification of phytochemical constituents in the leaf extracts of Azima tetracantha Lam using Gas Chromatography-Mass Spectrometry (GC-MS) analysis and antioxidant activity
El Dareer et al. Disposition of 2‐hydroxy‐4‐methoxybenzophenone in rats dosed orally, intravenously, or topically
Hanganu et al. Phytochemical analysis of isoflavons from some Fabaceae species extracts
JPH0477730B2 (en)
JPS58167512A (en) Antitrichophytic agent
DE19716660C2 (en) Preparations, in particular pharmaceutical and pharmaceutical forms based on plants, for combating Helicobacter pylori infections
Bhuiyan et al. Essential oil in roots of Vetiveria zizanioides (L.) Nash ex Small from Bangladesh
JP5980292B2 (en) β-secretase inhibitor and acetylcholinesterase inhibitor
Marcelle et al. Studies of zoapatle I. The extraction of zoapatle (Montanoa tomentosa) and the identification of 21-normontanol as the initial decomposition product of zoapatanol
Udvardy et al. A perspective on the anti-infective activity of Goldenseal (Hydrastis Canadensis) and its contribution to the development of multidrug pump inhibitors
Wang et al. Measurement of pharmacokinetics and tissue distribution of three bioactive constituents from Zanthoxylum armatum DC in rat plasma and tissues through UFLC-MS/MS
JP4220687B2 (en) Testosterone 5α-reductase inhibitor
Punia et al. Isolation, characterization and biological potential of compounds from flowers of Moringa oleifera
Quilhot et al. Studies on Chilean lichens, VI. Depsidones from Erioderma chilense
Duru et al. In Silico Docking Studies of Bioactive Compounds in Ocimum gratissimum Essential Oil againstCandidapepsin-1 Enzyme from Candida albicans: doi. org/10.26538/tjnpr/v5i2. 26
JPS5598112A (en) Liquid medicine for external use